Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance

DSpace/Manakin Repository

Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance

Citable link to this page

 

 
Title: Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance
Author: Huang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-I; Lin, Yu-Ju; Tsai, Pei-Chien; Lin, Zu-Yau; Chan, Soa-Yu; Chen, Shinn-Cherng; Yang, Hwai-I; Huang, Jee-Fu; Lu, Sheng-Nan; Dai, Chia-Yen; Jen, Chin-Lan; Yuan, Yong; L’Italien, Gilbert; Wang, Li-Yu; Lee, Mei-Hsuan; Yu, Ming-Lung; Chuang, Wan-Long; Chen, Chien-Jen

Note: Order does not necessarily reflect citation order of authors.

Citation: Huang, C., M. Yeh, C. Huang, Y. Lin, P. Tsai, Z. Lin, S. Chan, et al. 2017. “Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance.” Oncotarget 8 (27): 43925-43933. doi:10.18632/oncotarget.14937. http://dx.doi.org/10.18632/oncotarget.14937.
Full Text & Related Files:
Abstract: Background/Aims Both spontaneous hepatitis C virus (HCV) clearance and the achievement of sustained virological response (SVR) by anti-viral therapy greatly reduce the incidence of hepatocellular carcinoma (HCC). The current study aimed to compare the risk of HCC between the two patient groups Methods: A total of 313 subjects with spontaneous HCV clearance (SC) and 564 age- and sex-matched patients in the treatment-induced SVR group were enrolled for analysis. Results: Nineteen (2.2%) of the 877 patients developed HCC during 6,963 person-years of follow-up. Fourteen (2.5%) SVR patients and 5 (1.6%) SC patients developed HCC (P=0.004). Cox regression analysis of factors predictive of HCC included SVR (versus SC: hazard ratio [HR]/ 95% confidence interval [CI]: 5.83/1.27-26.88), diabetes (HR/CI:3.41/1.21-9.58), and age (HR/CI: 1.07/1.01-1.14). Of the 564 SVR patients, eleven (5.9%) of the 187 patients with fibrosis stage 2-4 (F2-4) and 2 (0.9%) of the 226 patients with F01 developed HCC (P=0.01). Compared to SC subjects, only SVR patients with F2-4 (P<0.001) but not F0-1(P=0.60) had a higher risk of HCC development. Cox-regression analysis using liver fibrosis as a variable demonstrated that factors associated with HCC included SVR with F2-4 (versus SC: HR/CI: 10.06/2.20-45.98), diabetes (HR/CI:3.23/1.14-9.19), and age (HR/CI: 1.08 1.02-1.15). Conclusions: Compared to subjects with spontaneous viral clearance, subjects with antiviral treatment-induced HCV viral clearance remain at high risk for HCC development, especially if they have significant hepatic fibrosis. These results may provide important information for decision-making regarding the prioritization of current direct antiviral agents in resource-limited countries.
Published Version: doi:10.18632/oncotarget.14937
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546450/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:34375119
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters